“…Up [195] miR-215 Up [199] MM CD38, CD138, CD147 Up [66,195,200] CD44 Up [201] let-7b, miR-18a Down [202] CLL CD19, CD37 Up [203] CD52 Up [139] CD19, CD5, CD44, CD31, CD55, CD82, CD62L, HLA-A, B, C, HLA-DR Up [204] CD49c, CD21, CD63 Down [204] miR-155 Up [205] HL CD30 Down [195] miR-155, miR-127, miR-21, let-7 Up [195,206] WL miR-155 Up [195,207] EVs in drug resistance. Cancer cells often acquire resistance by decreased accumulation of drugs inside the cells, increased drug efflux outside the cells, compartmentalization of drugs, and alteration of cellular pathways targeted by specific drugs [208].…”